ReN-003

N/A

Report date: 2022/11/05 14:35:27

Base Information

Drug NameReN-003
Drug Alias NameReN003hRPC therapy-ReNeuronReN-003
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Retinal progenitor cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSchepens Eye Research Institute IncReneuron LtdHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdReneuron Ltd
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A